🇺🇸 FDA
Patent

US 12023309

Enhanced delivery epinephrine compositions

granted A61KA61K31/085A61K31/137

Quick answer

US patent 12023309 (Enhanced delivery epinephrine compositions) held by Aquestive Therapeutics, Inc. expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aquestive Therapeutics, Inc.
Grant date
Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/085, A61K31/137, A61K36/61, A61K47/10